DOCSLIB.ORG

Subject Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subject Index Subject Index 84 905 induction ofcontractions in guinea-pig intestinal A effect of galIamine, gallopamil and nifedipine on smooth muscle, effect of pardaxin, 82, 43 response to, in taenia of the guinea-pig caecum. induction ofcontractions, effect ofnisoldipine in A23187, induction of relaxations in vascular smooth 83, 145 skinned or intact muscles in rabbit coronary muscle, effect of endothelial damage, 87, 713 effect of guanethidine on content of rat sym- arteries, 33, 243 -,release of prostacyclin and prostaglandin E2 pathetic ganglia, 82, 827 induction ofcontractions in cat tracheal smooth from pig aortic endothelial cells, bioassay, 87, effect of 5-HT spontaneous and electrically- muscle, effect of isoprenaline, 83, 677 685 evoked release from guinea-pig myenteric plexus, induction ofcontractions in cat tracheal smooth -,see Calcium Ionopbore A23187 88, 85, 529 muscle, role of stored calcium, 3, 667 A23187, effect on human neutrophil chemokinesis effect of ketamine and pentobarbitone on rat -,induction of contractions of guinea-pig lung and granular enzyme secretion, 91, 557 cerebral cortex concentrations, 82, 339 parenchyma strips, 34, 801 Abdominal comtriction test, sensitivity to gs- and effect of MDL 12, 330A in frog pectoris nerve- induction ofcontractions ofsmooth muscle in rat s-opioid receptor agonists in the mouse, 91, 823 muscle preparations on release, 88, 799 fundus, 34, 897 Abnormal automacity, barium- or strophanthidin- effect of methylxanthines on release from induction of contractions in rat fundus, lack of induced, effect of mexiletine in sheep cardiac electrically-stimulated rat brain slices, 83, 69 involvement of calcium channels, 33, 837 Purkinje fibres, 36, 805 effect of morphine withdrawal on guinea-pig induction of contractions in rat uterus, ACC-7513, pharmacological activity in tissue from cerebral cortex release, 89, 853 antagonist activity of Mandevilla velutina com- different species, 84, 793 effect of neurotensin on release in guinea-pig pounds, 91, 199 ACC-93S8, parasympatholytic activity, 87, 87 ileum, 90, 545 induction of contractions in rat portal veins, Accelerometer, measurement of tremor in rats, 37, effect ofNippostrongylus brasifiensis infection on effect of calcium entry blockers, 92, 203 403 responses of rat intestine, 32, 883 induction of electrical and mechanical responses Accommodation, reduction by caffeine in rat hip- effect of normorphine or clonidine on responses in smooth muscle cells of rabbit saphenous pocampal pyramidal cells in vitro, 85, 163 of guinea-pig ileum, 83, 326 artery, effect ofatropine and pirenzepine, 92, 657 Accommodation reaponues, effect of agonists on effect of primycin on spontaneous release at induction of endothelium-dependent relaxation subsensitized monkey eye, 34, 193 neuromuscular junction of the garter snake, 81, of rabbit aorta, effects of antioxidants and Acetone pbenylbydrazone, affinity for catalytic and 61 hydroxylated eicosatetraenoic acid, 82, 765 supplementary binding sites on soybean lipox- effect ofsubstances P antagonists on tachykinin- induction of endothelium-dependent relaxations ygenase, 83, 959 stimulated release in guinea-pig ileum, 87, 73 ofrabbit coeliac arterial strips, effect ofgossypol, 3-Acetoxy-N-melbyl piperidine methiodide, action at effect on action of BRL34915 on guinea-pig 92, 237 muscarinic receptors present on ileum and atria isolated trachealis, 89, 395 induction of gastric ulceration, effect of GABA in vitro, 86, 163 effect on constrictor response to noradrenaline in in rats, 84, 618 4-Acetoxy-N-methylplperldine methiodide, agonist normal, diabetic, adrenalectomized and diabetic- induction of 13H]-NA-release from bovine cul- potency at M2 muscarinic receptors in guinea-pig adrenalectomized rats, 83, 635 tured adrenal chromaffin cells, effect of col- ileum, atria and bronchi, 85, 437 effect on contractile responses ofrat iris sphincter lagenase, 81, 599 Acetycholine, effect on electromechanical properties muscle, 85, 905 induction of ionic currents, mechanism of of the guinea-pig portal vein, 81, 427 effect on cysteamine-induced contractions in alphoxalone block, 32, 783 Acetyl (- )-carnitlne hlorlde, anti-arrhythmic effects guinea-pig ileum, 82, 791 induction of muscarinic depolarizarion, time on canine late ventricular arrhythmia, 82, 533 effect on GABA release from guinea-pig isolated course in guinea-pig myenteric neurones, 82, 85 Acetylciholne, action at muscarinic receptors present small intestine, 89, 787 induction ofrelaxation in rabbit isolated arteries, on ileum and atria in vitro, 86, 163 effect on histamine in rat and hamster peritoneal role of endothelial and non-endothelial prostag- -, action on bullfrog sympathetic ganglia, effect of mast cells, 81, 693 landins, 87, 521 kyotorphin and D-kyotorphin, 85, 629 effect on [3H]-NA release from rat atria and induction of relaxations in rubbed and intact -, action on frog neuromuscular junction, effect of rabbit ear artery, 84, 697 aorta, influence ofvascular endothelium, 39, 819 succinyl derivatives of N-tris (hydroxymethyl)- effect on isolated single rat myometrial cells in induction of relaxations in coronary arteries, methyl-2-aminoethane sulphonic acid, 34, 275 short-term primary culture, 88, 873 effect of removal of magnesium ions, 91, 449 -, action on M2-muscarinic receptors to excite rat effect on mechanical and electrical activities of -,induction of relaxation in rat isolated aortic locus coeruleus, 85, 733 rat uterine smooth muscle in calcium free rings, 91, 729 -, activation of ion channels in mouse diaphragm, medium, 82, 735 induction of sodium-dependent non-specific effect of diltiazem and verapamil, 92, 561 effect on mechanical properties of longitudinal desensitization of guinea-pig ileum, 90, 347 -, activation of single channel currents, effect of and circular muscle tissues of rat myometrium induction of spasm in guinea-pig isolated pentobarbitone in mammalian muscle, 85, 229 during gestation, 86, 247 trachealis, effect of verapamil, 81, 499 -,agonist potency at M2 muscarinic receptors in effect on NA, phenylephrine and prostaglandin induction of spasm in guinea-pig isolated guinea-pig ileum, atria and bronchi, 85, 437 F2,-induced contractions in rat aorta complete trachealis, effect of nifedipine, 34, 861 -,changes in mechanical responses of vascular with endothelium, 85, 481 induction ofwrithing response in mouse, effect of smooth muscles in hypercholesterolemic rabbits, effect on oesophageal muscularis mucosae ofcat, chronic morphine treatment and withdrawal, 83, 87, 395 dog and American opossum, 83, 329 863 -,contractile effect in guinea-pig isolated trachea, effect on production of inositol, 1,4,5- induction ofwrithing response in mouse, effect of effect of epithelium, 37, 5 triphosphate in smooth muscle cells of dog morphine, 83, 853 -, contractile effects on guinea-pig isolated bronchi, trachea, 86, 191 inhibition byatropine orquinidine in myocardial 86, 367 ,effect on respiratory frequency in brainstem- preparations of cat heart, 81, 103 -, D2-dopamine receptor-mediated inhibition of spinal cord preparation of newborn rat, 86, 95, -,inhibition by dopamine of release in rabbit release from guinea-pig neostriatal slices, 91, 287 effect on systemic blood pressure in cats, 83, 347 isolated rectococcygeus muscle, 83, 871 -, dissociation constants and relative efficacy at ,effect on trigeminal antidromic vasodilatation -,inhibition of release by opioids in guinea-pig muscarinic receptors in guinea-pig ileum, 89, 7 and plasma extravasation in the rat, 34, 637 myenteric plexus, 85, 805 -,effect of M2-adrenoceptor antagonists on effects on the components of the cardiac mus- -,interactions with antagonists at prejunctional excitatory responses of rat cerebral cortex, 82, carinic receptor, 92, 327 muscarinic receptor in rabbit ear artery, 37, 733 453 failure of Bay K 8644 to increase the release from interactions with Bay K 8644 in guinea-pig -,effect of bicuculline on release from guinea-pig nerve terminals in rat brain and diaphragm, 91, trachealis, 36, 171 isolated colon, 90, 31 475 in the presence of physostigmine, production of -, effect ofchronic caffeine on release stimulated by increased levels in brains of 'old' rats following inotropic effects in mammalian ventricular caffeine or adenosine in rats, 33, 671 treatment with pyrithioxin, 90, 561 myocardium, 90, 81 -,effect of cyclo-oxygenase inhibitors on release induction of bronchoconstriction in guinea-pig, mechanism of adrenaline inhibition of release in from guinea-pig longitudinal muscle strips, 82, effect of gallamine, 83, 973 bullfrog sympathetic ganglia, 4, 435 577 induction of bronchoconstriction in guinea-pig, muscarnic responses of guinea-pig myenteric -,effect of diacyglycerol and phorbol ester on effect of vanadate, 92, 173 plexus, effect of GABA, 82, 101 release in mice, 90, 327 induction of contractions in rat uterine smooth output in human perfused placental cotyleda, 88, -,effect of epithelium removal on sensitivity of muscle in calcium-free medium, 31, 317 301 guinea-pig isolated trachea, 37, 501 induction of contractions, effects of organic overflow accompanying RT stimulation in -, effect of exposure time on the muscarinic inhibi- calcium antagonists in guinea-pig isolated chicken rectum, 2, 73 tion of [3H]-NA overflow from guinea-pig atria, trachea, 82, 727 potentiation of contractions to field stimulation 32 SUBJECT INDEX of rat vas deferens, 86, 671 rat, 86, 69 effect on cortical ACh release in rats, 88, 671 -,production of end-plate depolarization, effect
Load more

Recommended publications
  • GABA Receptors
    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
    [Show full text]
  • Cell Surface Mobility of GABAB Receptors Saad Bin
    Cell surface mobility of GABAB receptors Saad Bin Hannan September 2011 A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy of the University College London Department of Neuroscience, Physiology, and Pharmacology University College London Gower Street London WC1E 6BT UK Declaration ii ‘I, Saad Hannan confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis.' ____________________ Saad Hannan September 2011 To Ammu, Abbu, Polu Abstract ivi Abstract Type-B γ-aminobutyric acid receptors (GABABRs) are important for mediating slow inhibition in the central nervous system and the kinetics of their internalisation and lateral mobility will be a major determinant of their signalling efficacy. Functional GABABRs require R1 and R2 subunit co-assembly, but how heterodimerisation affects the trafficking kinetics of GABABRs is unknown. Here, an α- bungarotoxin binding site (BBS) was inserted into the N-terminus of R2 to monitor receptor mobility in live cells. GABABRs are internalised via clathrin- and dynamin- dependent pathways and recruited to endosomes. By mutating the BBS, a new technique was developed to differentially track R1a and R2 simultaneously, revealing the subunits internalise as heteromers and that R2 dominantly-affects constitutive internalisation of GABABRs. Notably, the internalisation profile of R1aR2 heteromers, but not R1a homomers devoid of their ER retention motif (R1ASA), is similar to R2 homomers in heterologous systems. The internalisation of R1aASA was slowed to that of R2 by mutating a di-leucine motif in the R1 C-terminus, indicating a new role for heterodimerisation, whereby R2 subunits slow the internalization of surface GABABRs.
    [Show full text]
  • WO 2012/044761 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . 5 April 2012 (05.04.2012) WO 2012/044761 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/48 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/US201 1/053876 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 29 September 201 1 (29.09.201 1) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Langi English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 12/893,344 29 September 2010 (29.09.2010) US (84) Designated States (unless otherwise indicated, for every (71) Applicant (for all designated States except US): UNI¬ kind of regional protection available): ARIPO (BW, GH, VERSITY OF NORTH CAROLINA AT WILMING¬ GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, TON [US/US]; 601 South College Road, Wilmington, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, NC 28403 (US).
    [Show full text]
  • And Angiotensin II- Induced Changes by Calcium Antagonists in the Peripheral Circulation Ofanaesthetized Rabbits Robert P
    Br. J. Pharmac. (1985), 85, 75-87 Modification ofvasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation ofanaesthetized rabbits Robert P. Hof Cardiovascular Unit of Preclinical Research, Sandoz Ltd, CH-4002 Basel, Switzerland 1 Investigations into the site of vasodilator and antivasoconstrictor activity of calcium antagonists previously performed in cats were extended to a second species, barbiturate-anaesthetized rabbits, and a second vasoconstrictor agent, vasopressin. 2 The dihydropyridine derivative darodipine (code name PY 108-068; 10, 30 and 100 pg kg-' i.v.) showed systemic haemodynamic effects comparable to those seen in cats at half these doses. Darodipine effected regional vasodilatation (measured with tracer microspheres) in the heart, brain and skeletal muscles as in cats. Only the vessels of the adrenals (dilated in rabbits but not in cats), and the kidneys and skin (constricted in rabbits but not in cats) responded differently to darodipine. 3 Angiotensin II (A II; 0.15 and 1.5 yg kg- min ')constricted the same vascular beds in rabbits as in cats, namely the heart, kidneys, small intestine, pancreas, spleen, skin and arterio-venous shunts (inferred from microspheres reaching the lungs), the only exceptions being the vessels of the stomach and liver (constriction only in cats) and the adrenals (constriction only in rabbits). 4 Darodipine (30 and 100 yg kg-') attenuated the A II-induced vasoconstriction in the same vascular beds in rabbits as in cats including the kidneys, which were constricted after administration of the antagonist alone. 5 These results indicate surprisingly small species differences for the vasodilator effects of darodipine as well as the attenuation of the vasoconstrictor effects of A II.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Isoguvacine Hydrochloride | Medchemexpress
    Inhibitors Product Data Sheet Isoguvacine hydrochloride • Agonists Cat. No.: HY-100810 CAS No.: 68547-97-7 Molecular Formula: C₆H₁₀ClNO₂ • Molecular Weight: 163.6 Screening Libraries Target: GABA Receptor Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling Storage: Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month SOLVENT & SOLUBILITY In Vitro H2O : ≥ 100 mg/mL (611.25 mM) DMSO : 25 mg/mL (152.81 mM; Need ultrasonic) * "≥" means soluble, but saturation unknown. Mass Solvent 1 mg 5 mg 10 mg Concentration Preparing 1 mM 6.1125 mL 30.5623 mL 61.1247 mL Stock Solutions 5 mM 1.2225 mL 6.1125 mL 12.2249 mL 10 mM 0.6112 mL 3.0562 mL 6.1125 mL Please refer to the solubility information to select the appropriate solvent. In Vivo 1. Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline Solubility: ≥ 2.08 mg/mL (12.71 mM); Clear solution 2. Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline) Solubility: ≥ 2.08 mg/mL (12.71 mM); Clear solution 3. Add each solvent one by one: 10% DMSO >> 90% corn oil Solubility: ≥ 2.08 mg/mL (12.71 mM); Clear solution BIOLOGICAL ACTIVITY Description Isoguvacine hydrochloride is a GABA receptor agonist. IC₅₀ & Target GABA[1] In Vitro Isoguvacine binds to a mouse forebrain synaptic membrane preparation. The specific binding is displaceable by GABA, Page 1 of 2 www.MedChemExpress.com muscimol and bicuculline but not by picrotoxin or diaminobutyric acid.
    [Show full text]
  • Programa / Program
    ABSTRACTS / RESÚMENES LUNES 13 DE DICIEMBRE / MONDAY, DECEMBER 13 INAUGURAL PLENARY LECTURES / CONFERENCIAS PLENARIAS INAUGURALES PL-01 THE CONCURRENT CHALLENGES OF EFFECTIVENESS RESEARCH AND INDIVIDUALIZED THERAPEUTIC STRATEGIES Gianni Tognoni South Institute for Pharmacological Research, Santa María Imbaro, Chiety, Italy. email: [email protected] The proposal of focusing the attention on the two apparent extremes of care (on one side the public health relevance and transferability of the paradygm of EBM, on the other side one of the expected clinical yields of genomic-translational research) aims to underline and exemplify the strict complementarity of the two scenarios. Methodologically and operationally, both approaches do propose a very promising future for the development of pharmacological research, with closer links to the highly productive area of outcomes- oriented epidemiology and with the most advanced sector of basic sciences. It seems specifically important that the two areas could be developed in close interaction, possibly within the same department(s), to assure a productive interplay of competences in the collaboration with clinical care, as well as in the training of the new generations of pharmacologists, pharmacists, clinicians. PL-02 BASIC PERIPHERAL MOLECULAR COMPONENTS OF INFLAMMATORY PAIN H Ferreira School of Medicine of Ribeirão Preto. Department of Pharmacology, Campus USP, Ribeirão Preto, SP. Brazil. email: [email protected] When non steroidal anti-inflammatory drugs mechanism of action was discovered, I proposed that their analgesic effect resulted from the prevention of the nociceptor sensitization by prostaglandins. Thus, pain in an inflammatory process results from an action of mechanical, thermal or chemical stimuli upon sensitized nociceptors (hiperalgesia, hypernociception-HPr).
    [Show full text]
  • Gabaergic Signaling Linked to Autophagy Enhances Host Protection Against Intracellular Bacterial Infections
    ARTICLE DOI: 10.1038/s41467-018-06487-5 OPEN GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections Jin Kyung Kim1,2,3, Yi Sak Kim1,2,3, Hye-Mi Lee1,3, Hyo Sun Jin4, Chiranjivi Neupane 2,5, Sup Kim1,2,3, Sang-Hee Lee6, Jung-Joon Min7, Miwa Sasai8, Jae-Ho Jeong 9,10, Seong-Kyu Choe11, Jin-Man Kim12, Masahiro Yamamoto8, Hyon E. Choy 9,10, Jin Bong Park 2,5 & Eun-Kyeong Jo1,2,3 1234567890():,; Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the brain; however, the roles of GABA in antimicrobial host defenses are largely unknown. Here we demonstrate that GABAergic activation enhances antimicrobial responses against intracel- lular bacterial infection. Intracellular bacterial infection decreases GABA levels in vitro in macrophages and in vivo in sera. Treatment of macrophages with GABA or GABAergic drugs promotes autophagy activation, enhances phagosomal maturation and antimicrobial responses against mycobacterial infection. In macrophages, the GABAergic defense is mediated via macrophage type A GABA receptor (GABAAR), intracellular calcium release, and the GABA type A receptor-associated protein-like 1 (GABARAPL1; an Atg8 homolog). Finally, GABAergic inhibition increases bacterial loads in mice and zebrafish in vivo, sug- gesting that the GABAergic defense plays an essential function in metazoan host defenses. Our study identified a previously unappreciated role for GABAergic signaling in linking antibacterial autophagy to enhance host innate defense against intracellular bacterial infection. 1 Department of Microbiology, Chungnam National University School of Medicine, Daejeon 35015, Korea. 2 Department of Medical Science, Chungnam National University School of Medicine, Daejeon 35015, Korea.
    [Show full text]
  • Marine Pharmacology in 1999: Compounds with Antibacterial
    Comparative Biochemistry and Physiology Part C 132 (2002) 315–339 Review Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action Alejandro M.S. Mayera, *, Mark T. Hamannb aDepartment of Pharmacology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA bSchool of Pharmacy, The University of Mississippi, Faser Hall University, MS 38677, USA Received 28 November 2001; received in revised form 30 May 2002; accepted 31 May 2002 Abstract This review, a sequel to the 1998 review, classifies 63 peer-reviewed articles on the basis of the reported preclinical pharmacological properties of marine chemicals derived from a diverse group of marine animals, algae, fungi and bacteria. In all, 21 marine chemicals demonstrated anthelmintic, antibacterial, anticoagulant, antifungal, antimalarial, antiplatelet, antituberculosis or antiviral activities. An additional 23 compounds had significant effects on the cardiovascular, sympathomimetic or the nervous system, as well as possessed anti-inflammatory, immunosuppressant or fibrinolytic effects. Finally, 22 marine compounds were reported to act on a variety of molecular targets, and thus could potentially contribute to several pharmacological classes. Thus, during 1999 pharmacological research with marine chemicals continued
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
    Supplementary Online Content Karmali KN, Lloyd-Jones DM, Berendsen MA, et al. Drugs for primary prevention of atherosclerotic cardiovascular disease: an overview of systematic reviews. JAMA Cardiol. Published online April 27, 2016. doi:10.1001/jamacardio.2016.0218. eAppendix 1. Search Documentation Details eAppendix 2. Background, Methods, and Results of Systematic Review of Combination Drug Therapy to Evaluate for Potential Interaction of Effects eAppendix 3. PRISMA Flow Charts for Each Drug Class and Detailed Systematic Review Characteristics and Summary of Included Systematic Reviews and Meta-analyses eAppendix 4. List of Excluded Studies and Reasons for Exclusion This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. 1 Downloaded From: https://jamanetwork.com/ on 09/28/2021 eAppendix 1. Search Documentation Details. Database Organizing body Purpose Pros Cons Cochrane Cochrane Library in Database of all available -Curated by the Cochrane -Content is limited to Database of the United Kingdom systematic reviews and Collaboration reviews completed Systematic (UK) protocols published by by the Cochrane Reviews the Cochrane -Only systematic reviews Collaboration Collaboration and systematic review protocols Database of National Health Collection of structured -Curated by Centre for -Only provides Abstracts of Services (NHS) abstracts and Reviews and Dissemination structured abstracts Reviews of Centre for Reviews bibliographic
    [Show full text]
  • Marine Pharmacology in 2003–4: Marine
    Comparative Biochemistry and Physiology, Part C 145 (2007) 553–581 www.elsevier.com/locate/cbpc Marine pharmacology in 2003–4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action ⁎ Alejandro M.S. Mayer a, , Abimael D. Rodríguez b, Roberto G.S. Berlinck c, Mark T. Hamann d a Department of Pharmacology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, Illinois 60515, USA b Department of Chemistry, University of Puerto Rico, San Juan, Puerto Rico 00931, USA c Instituto de Quimica de Sao Carlos, Universidade de Sao Paulo, Sao Carlos, 13560-970, Brazil d School of Pharmacy, The University of Mississippi, Faser Hall, University, Mississippi 38677, USA Received 28 October 2006; received in revised form 29 January 2007; accepted 30 January 2007 Available online 9 February 2007 Abstract The current marine pharmacology review that covers the peer-reviewed literature during 2003 and 2004 is a sequel to the authors' 1998–2002 reviews, and highlights the preclinical pharmacology of 166 marine chemicals derived from a diverse group of marine animals, algae, fungi and bacteria. Anthelmintic, antibacterial, anticoagulant, antifungal, antimalarial, antiplatelet, antiprotozoal, antituberculosis or antiviral activities were reported for 67 marine chemicals. Additionally 45 marine compounds were shown to have significant effects on the cardiovascular, immune and nervous system as well as possessing anti-inflammatory effects. Finally, 54 marine compounds were reported to act on a variety of molecular targets and thus may potentially contribute to several pharmacological classes.
    [Show full text]